Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.
Boogerd LSF, Hoogstins CES, Gaarenstroom KN, de Kroon CD, Beltman JJ, Bosse T, Stelloo E, Vuyk J, Low PS, Burggraaf J, Vahrmeijer AL. Boogerd LSF, et al. Among authors: vuyk j. Oncotarget. 2017 Dec 11;9(1):791-801. doi: 10.18632/oncotarget.23155. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416655 Free PMC article.
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Tummers QR, Hoogstins CE, Gaarenstroom KN, de Kroon CD, van Poelgeest MI, Vuyk J, Bosse T, Smit VT, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Tummers QR, et al. Among authors: vuyk j. Oncotarget. 2016 May 31;7(22):32144-55. doi: 10.18632/oncotarget.8282. Oncotarget. 2016. PMID: 27014973 Free PMC article. Clinical Trial.
A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.
Hoogstins CE, Tummers QR, Gaarenstroom KN, de Kroon CD, Trimbos JB, Bosse T, Smit VT, Vuyk J, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Hoogstins CE, et al. Among authors: vuyk j. Clin Cancer Res. 2016 Jun 15;22(12):2929-38. doi: 10.1158/1078-0432.CCR-15-2640. Clin Cancer Res. 2016. PMID: 27306792 Clinical Trial.
Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, van Erkel AR, van der Velde CJH, Kapiteijn E, Vahrmeijer AL. de Leede EM, et al. Among authors: vuyk j. Cardiovasc Intervent Radiol. 2017 Aug;40(8):1196-1205. doi: 10.1007/s00270-017-1630-4. Epub 2017 Apr 27. Cardiovasc Intervent Radiol. 2017. PMID: 28451811 Free PMC article. Clinical Trial.
Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, van Erkel AR, van der Velde CJH, Kapiteijn E, Vahrmeijer AL. de Leede EM, et al. Among authors: vuyk j. Cardiovasc Intervent Radiol. 2017 Dec;40(12):1966. doi: 10.1007/s00270-017-1766-2. Cardiovasc Intervent Radiol. 2017. PMID: 28840267 Free PMC article. No abstract available.
Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms.
van Duinen N, Steenvoorden D, Bonsing BA, Vuyk J, Vriends AH, Jansen JC, Romijn JA, Corssmit EP. van Duinen N, et al. Among authors: vuyk j. Eur J Endocrinol. 2010 Jul;163(1):121-7. doi: 10.1530/EJE-10-0114. Epub 2010 Apr 30. Eur J Endocrinol. 2010. PMID: 20435616
59 results